Documents
Application Sponsors
ANDA 205239 | MYLAN INSTITUTIONAL | |
Marketing Status
Application Products
001 | INJECTABLE;INJECTION | 20MG/VIAL | 0 | DANTROLENE SODIUM | DANTROLENE SODIUM |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2016-02-18 | STANDARD |
Submissions Property Types
CDER Filings
MYLAN INSTITUTIONAL
cder:Array
(
[0] => Array
(
[ApplNo] => 205239
[companyName] => MYLAN INSTITUTIONAL
[docInserts] => ["",""]
[products] => [{"drugName":"DANTROLENE SODIUM","activeIngredients":"DANTROLENE SODIUM","strength":"20MG\/VIAL","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
[labels] => [{"actionDate":"02\/18\/2016","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/205239Orig1s000lbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"02\/18\/2016","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2016\\\/205239Orig1s000lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2016\\\/205239Orig1s000ltr.pdf\"}]","notes":">"}]
[supplements] =>
[actionDate] => 2016-02-18
)
)